37 related articles for article (PubMed ID: 19490146)
1. Measles virus V protein inhibits p53 family member p73.
Cruz CD; Palosaari H; Parisien JP; Devaux P; Cattaneo R; Ouchi T; Horvath CM
J Virol; 2006 Jun; 80(11):5644-50. PubMed ID: 16699046
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling.
Ou B; Sun H; Zhao J; Xu Z; Liu Y; Feng H; Peng Z
J Exp Clin Cancer Res; 2019 Oct; 38(1):426. PubMed ID: 31655629
[TBL] [Abstract][Full Text] [Related]
3. Plk3 functions as an essential component of the hypoxia regulatory pathway by direct phosphorylation of HIF-1alpha.
Xu D; Yao Y; Lu L; Costa M; Dai W
J Biol Chem; 2010 Dec; 285(50):38944-50. PubMed ID: 20889502
[TBL] [Abstract][Full Text] [Related]
4.
Jones W; Tait D; Livasy C; Ganapathi M; Ganapathi R
NAR Cancer; 2022 Sep; 4(3):zcac026. PubMed ID: 36177381
[TBL] [Abstract][Full Text] [Related]
5. The p53 family member p73 in the regulation of cell stress response.
Rozenberg JM; Zvereva S; Dalina A; Blatov I; Zubarev I; Luppov D; Bessmertnyi A; Romanishin A; Alsoulaiman L; Kumeiko V; Kagansky A; Melino G; Ganini C; Barlev NA
Biol Direct; 2021 Nov; 16(1):23. PubMed ID: 34749806
[TBL] [Abstract][Full Text] [Related]
6. Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors.
Omran Z; H Dalhat M; Abdullah O; Kaleem M; Hosawi S; A Al-Abbasi F; Wu W; Choudhry H; Alhosin M
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921128
[TBL] [Abstract][Full Text] [Related]
7. The role of polo-like kinase 3 in the response of BRAF-mutant cells to targeted anticancer therapies.
Babagana M; Kichina JV; Slabodkin H; Johnson S; Maslov A; Brown L; Attwood K; Nikiforov MA; Kandel ES
Mol Carcinog; 2020 Jan; 59(1):5-14. PubMed ID: 31571292
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinases and acute leukemia.
Goroshchuk O; Kolosenko I; Vidarsdottir L; Azimi A; Palm-Apergi C
Oncogene; 2019 Jan; 38(1):1-16. PubMed ID: 30104712
[TBL] [Abstract][Full Text] [Related]
9. MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growth.
Liu S; Liu F; Huang W; Gu L; Meng L; Ju Y; Wu Y; Li J; Liu L; Sang M
Oncotarget; 2018 Jan; 9(3):3365-3378. PubMed ID: 29423052
[TBL] [Abstract][Full Text] [Related]
10. The role of Plk3 in oncogenesis.
Helmke C; Becker S; Strebhardt K
Oncogene; 2016 Jan; 35(2):135-47. PubMed ID: 25915845
[TBL] [Abstract][Full Text] [Related]
11. A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.
Engelmann D; Meier C; Alla V; Pützer BM
Oncogene; 2015 Aug; 34(33):4287-99. PubMed ID: 25381823
[TBL] [Abstract][Full Text] [Related]
12. p73-Binding Partners and Their Functional Significance.
Ozaki T; Kubo N; Nakagawara A
Int J Proteomics; 2010; 2010():283863. PubMed ID: 22084676
[TBL] [Abstract][Full Text] [Related]
13. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
Al-Bahlani S; Fraser M; Wong AY; Sayan BS; Bergeron R; Melino G; Tsang BK
Oncogene; 2011 Oct; 30(41):4219-30. PubMed ID: 21516125
[TBL] [Abstract][Full Text] [Related]
14. Calcium- and integrin-binding protein 1 regulates endomitosis and its interaction with Polo-like kinase 3 is enhanced in endomitotic Dami cells.
Kostyak JC; Naik UP
PLoS One; 2011 Jan; 6(1):e14513. PubMed ID: 21264284
[TBL] [Abstract][Full Text] [Related]
15. Polo-box domain: a versatile mediator of polo-like kinase function.
Park JE; Soung NK; Johmura Y; Kang YH; Liao C; Lee KH; Park CH; Nicklaus MC; Lee KS
Cell Mol Life Sci; 2010 Jun; 67(12):1957-70. PubMed ID: 20148280
[TBL] [Abstract][Full Text] [Related]
16. Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation.
Sang M; Ando K; Okoshi R; Koida N; Li Y; Zhu Y; Shimozato O; Geng C; Shan B; Nakagawara A; Ozaki T
Genes Cells; 2009 Jul; 14(7):775-88. PubMed ID: 19490146
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.
Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A
J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154
[TBL] [Abstract][Full Text] [Related]
18. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
Paliwal P; Radha V; Swarup G
BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
[TBL] [Abstract][Full Text] [Related]
19. Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase.
Jones EV; Dickman MJ; Whitmarsh AJ
Biochem J; 2007 Aug; 405(3):617-23. PubMed ID: 17521288
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
